We provide contract analysis services utilizing mass spectrometry imaging. This technology enables visualization of “where, what components, and how much.” It is applicable to pharmacokinetic studies, cosmetic development, and various other fields.
The University of Osaka–developed “next-generation microfluidic PCR technology” is leveraged to deliver a rapid and easy-to-use gut microbiome testing service, and to operate a community platform business that connects people with digestive concerns with companies offering products to support gut health. We also provide contract testing services for gut microbiome analysis.
We provide a system that analyzes medical images using AI and outputs musculoskeletal data.
Development of cancer treatment equipment using optical electromagnetic waves
Development of technology for assessing micronutrient intake using hair and provision of analysis services.